BridgeMD
New treatment option for Gastrointestinal Motility
Official title Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects
ClinicalTrials.gov ID: NCT07496697
What this study is testing
- What it's testing
- This study aims to investigate how a specific combination of electroacupuncture points, Tongbian (NP82) and Daheng (SP15), affects bowel movements in healthy volunteers. Constipation is a significant health issue, especially for post-stroke patients, and current treatments like laxatives often have unwanted side effects.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Healthy volunteers aged 18 years and older.
- No symptoms related to constipation after comprehensive evaluation based on Rome IV criteria.
- No gastrointestinal symptoms (abdominal pain, diarrhea, blood in stool, constipation, or bloating) in the 4 weeks prior to study participation.
- No use of medications that promote or inhibit bowel motility in the 4 weeks prior to participation (including prokinetics, laxatives, antispasmodics...
- Fasting for at least 4 hours before the study session.
You likely can't join if
- Participants with severe medical conditions (heart, brain, liver, kidney, hematological system, infectious diseases, cancer, or psychiatric...
- Metabolic or functional disorders such as irritable bowel syndrome (IBS), thyroid dysfunction, or glucose/lipid metabolism disorders.
- Use of bowel motility-altering medications within the 4 weeks prior to participation.
- Participation in other clinical trials within the last 2 months.
- Received acupuncture treatment within the last month.
- Skin ulcers, abscesses, or infections at the acupuncture sites.
See the full eligibility criteria
- Healthy volunteers aged 18 years and older.
- No symptoms related to constipation after comprehensive evaluation based on Rome IV criteria.
- No gastrointestinal symptoms (abdominal pain, diarrhea, blood in stool, constipation, or bloating) in the 4 weeks prior to study participation.
- No use of medications that promote or inhibit bowel motility in the 4 weeks prior to participation (including prokinetics, laxatives, antispasmodics, or opioids).
- Fasting for at least 4 hours before the study session.
- No mental or intellectual disorders; capable of understanding the acupuncture and assessment procedures.
- Willingness to participate and signed informed consent form.
- Participants with severe medical conditions (heart, brain, liver, kidney, hematological system, infectious diseases, cancer, or psychiatric disorders).
- Metabolic or functional disorders such as irritable bowel syndrome (IBS), thyroid dysfunction, or glucose/lipid metabolism disorders.
- Use of bowel motility-altering medications within the 4 weeks prior to participation.
- Participation in other clinical trials within the last 2 months.
- Received acupuncture treatment within the last month.
- Skin ulcers, abscesses, or infections at the acupuncture sites.
- Known metal allergy or severe needle phobia.
The study team makes the final eligibility decision.
Where it's taking place
- Ho Chi Minh City, Ho Chi Minh, Vietnam
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ho Chi Minh City, Ho Chi Minh, Vietnam. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.